Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117135) titled 'Safety analysis of rivaroxaban in clinical use' on Jan. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai Public Health Clinical Center
Condition:
Liver cirrhosis
Intervention:
Compensatory stage of liver cirrhosis:None
decompensated liver cirrhosis:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-03-17
Target Sample Size: Compensatory stage of liver cirrhosis:992;decompensated liver cirrhosis:992;Non-cirrhosis group:992;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299017
Discl...